Drug Shortage Report for PMS-IMATINIB

Last updated on 2020-06-10 History
Report ID 7370
Drug Identification Number 02431122
Brand name PMS-IMATINIB
Common or Proper name IMATINIB
Company Name PHARMASCIENCE INC
Market Status DORMANT
Active Ingredient(s) IMATINIB
Strength(s) 400MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30
ATC code L01XE
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Demand increase for the drug.
Anticipated start date 2017-05-20
Actual start date 2017-07-30
Estimated end date Unknown
Actual end date 2020-06-09
Shortage status Resolved
Updated date 2020-06-10
Company comments No more supplier
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v17 2020-06-10 French Compare
v16 2020-06-10 English Compare
v15 2019-09-12 French Compare
v14 2019-09-12 English Compare
v13 2019-07-31 French Compare
v12 2019-07-31 English Compare
v11 2019-06-11 French Compare
v10 2019-06-11 English Compare
v9 2017-10-11 French Compare
v8 2017-10-11 English Compare
v7 2017-07-25 French Compare
v6 2017-07-25 English Compare
v5 2017-06-16 French Compare
v4 2017-06-16 English Compare
v3 2017-05-21 English Compare
v2 2017-04-20 French Compare
v1 2017-04-20 English Compare

Showing 1 to 17 of 17